Jove
Visualize
Contact Us

Related Experiment Videos

Chromosome 22 abnormalities in Ewing's sarcoma.

E V Davison1, A D Pearson, J Emslie

  • 1Department of Human Genetics, University of Newcastle upon Tyne.

Journal of Clinical Pathology
|August 1, 1989
PubMed
Summary

This study investigated chromosome 22 rearrangements in a child with disseminated Ewing's sarcoma. Findings suggest chromosome 22 is crucial, but the classic t(11;22) translocation may not be essential for all cases.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

TRADE: tolerability of adjuvant abemaciclib at 6 months after initial dose escalation in patients with early-stage HR-positive/HER2-negative breast cancer.

ESMO open·2026
Same author

TRADE: a phase II trial to assess the tolerability of abemaciclib dose escalation in early-stage HR-positive/HER2-negative breast cancer.

Annals of oncology : official journal of the European Society for Medical Oncology·2025
Same author

Purified Human Pancreatic Islets, CIT Culture Media with Lisofylline or Exenatide.

CellR4-- repair, replacement, regeneration, & reprogramming·2019
Same author

Long-term outcome of anorectal biofeedback for treatment of fecal incontinence.

Neurogastroenterology and motility·2018
Same author

The Oldest Coroner in England.

The Hospital·2018
Same author

SU-E-T-429: Image-Guided Eye Plaque Brachytherapy Optimization: Implications for Patients at 2-Year Follow-up.

Medical physics·2017
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Area of Science:

  • Oncology
  • Cytogenetics
  • Pediatric Cancer Research

Background:

  • Ewing's sarcoma is a rare bone cancer primarily affecting children and young adults.
  • Cytogenetic abnormalities, particularly translocations involving chromosome 11 and 22 (t(11;22)), are hallmarks of Ewing's sarcoma.
  • Understanding the genetic basis of Ewing's sarcoma is crucial for diagnosis, prognosis, and targeted therapies.

Observation:

  • A pediatric patient with disseminated Ewing's sarcoma presented with unique chromosomal alterations.
  • Cytogenetic analysis at diagnosis revealed a ring chromosome 22 (?ring22).
  • At relapse, the patient exhibited a t(10;22) translocation, but the canonical t(11;22) was absent.

Findings:

  • The case demonstrates structural rearrangements of chromosome 22 in Ewing's sarcoma.

Related Experiment Videos

  • The presence of ?ring22 at diagnosis and t(10;22) at relapse highlights variability in chromosomal abnormalities.
  • The absence of the classic t(11;22) translocation challenges its universal role in Ewing's sarcoma pathogenesis.

    • Implications:

    • Chromosome 22 plays a significant role in the development of Ewing's sarcoma.
    • The findings suggest alternative genetic pathways may drive Ewing's sarcoma progression.
    • Further research is needed to elucidate the prognostic and therapeutic implications of non-canonical chromosomal alterations in Ewing's sarcoma.